SUSTAINED VIRAL RESPONSE

This adverse event was reported 12 times

SUSTAINED VIRAL RESPONSE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR 1 0.0009
1 DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE 1 0.0006
2 ELBASVIR AND GRAZOPREVIR 1 0.0002
3 GLECAPREVIR AND PIBRENTASVIR 2 0.0002
4 VELPATASVIR AND SOFOSBUVIR 2 0.0002
5 MICAFUNGIN SODIUM 1 0.0002
6 REMDESIVIR 2 0.0002
7 RILPIVIRINE 1 0.0001
8 ITRACONAZOLE 1 0.0001
9 CEFEPIME HYDROCHLORIDE 1 0.0001
See all drugs enriched for association with SUSTAINED VIRAL RESPONSE